Respiratory News and Research

RSS

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Emergency departments across Michigan are more prepared to handle natural disaster

Emergency Departments across Michigan are better prepared to handle a disaster today than they were seven years ago, according to a Henry Ford Hospital study.

15 Oct 2013

Teva gets FDA approval for generic version of TOBI in US

Teva Pharmaceutical Industries Ltd. announces today that the U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI (Tobramycin Inhalation Solution USP) in the United States.

15 Oct 2013

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).

15 Oct 2013

No link to air toxics in pediatric asthma prevalence

A nationwide US study has found that early exposure to ambient air toxics does not associate with the prevalence of asthma in young children.

14 Oct 2013

Drug treatment ineffective for acute bronchitis

A study published in the BMJ indicates that neither oral antibiotics nor nonsteroidal anti-inflammatory drugs are more effective than placebo for the treatment of acute bronchitis.

14 Oct 2013

GE Healthcare to introduce new technologies at ANESTHESIOLOGY 2013

GE Healthcare will introduce several new technologies that demonstrate its ongoing commitment to improving the quality of patient care at ANESTHESIOLOGY 2013, the annual meeting of the American Society of Anesthesiologists, taking place October 12-16 in San Francisco.

12 Oct 2013

Scientists decode key molecular gateway for toxin that causes botulism

U.S. and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream.

12 Oct 2013

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi announced today that the U.S. Food and Drug Administration approved Nasacort Allergy 24HR nasal spray as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

12 Oct 2013

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

11 Oct 2013

Novel community program to improve the way childhood asthma controlled outside hospital

Indiana University School of Medicine emergency medicine faculty hope to improve the way childhood asthma is medically managed in Marion County through an innovative program that incorporates the skills and flexible schedules of specially trained Indianapolis Emergency Medical Services paramedics.

11 Oct 2013

Scientists develop new method to create stem cells for human liver and pancreas

A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.

11 Oct 2013

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted and filed the company's supplemental Biologics License Application for subcutaneous use of Xolair (omalizumab) in people with Chronic Idiopathic Urticaria who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses.

11 Oct 2013

Maternal fatty acid intake linked to infant wheeze

Japanese researchers have found that high intake of certain fatty acids by pregnant women is associated with a lower risk for wheeze during infancy in their offspring.

10 Oct 2013

Teva Cutting 5,000 Jobs In Global Restructuring

...

10 Oct 2013

Teleflex to showcase products and technologies at ANESTHESIOLOGY 2013 annual meeting

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, is committed to helping clinicians improve patient outcomes and reduce healthcare costs. Teleflex will showcase its broad portfolio of brands, products and technologies at the ANESTHESIOLOGY 2013 annual meeting, October 12-16, in San Francisco, CA.

10 Oct 2013

New MERS coronavirus emerged from bats to humans: Research

The newly emerged Middle East respiratory syndrome coronavirus has circulated in bats for a substantial time, before making the species leap to humans, according to research published in BioMed Central's open access publication Virology Journal.

10 Oct 2013

Researchers receive grant to improve outcomes for preterm infants who struggle to take first breaths

Monash University researchers have received a prestigious National Institutes of Health (NIH) project grant to find ways to improve outcomes for very preterm infants who struggle to take their first breaths.

10 Oct 2013

Asthma infection risk ‘goes beyond the airways’

Researchers from the USA have found that asthma may be associated with an increased risk for infections outside of the respiratory tract.

9 Oct 2013

Study explores impact of altitude and anemia in children with pneumonia

Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 meters or about 6,500 feet).

9 Oct 2013

Respiratory News and Research

Astrazeneca Acquires Spirogen For Up To $440M

Emergency departments across Michigan are more prepared to handle natural disaster

Teva gets FDA approval for generic version of TOBI in US

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

No link to air toxics in pediatric asthma prevalence

Drug treatment ineffective for acute bronchitis

GE Healthcare to introduce new technologies at ANESTHESIOLOGY 2013

Scientists decode key molecular gateway for toxin that causes botulism

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Novel community program to improve the way childhood asthma controlled outside hospital

Scientists develop new method to create stem cells for human liver and pancreas

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Maternal fatty acid intake linked to infant wheeze

Teva Cutting 5,000 Jobs In Global Restructuring

Teleflex to showcase products and technologies at ANESTHESIOLOGY 2013 annual meeting

New MERS coronavirus emerged from bats to humans: Research

Researchers receive grant to improve outcomes for preterm infants who struggle to take first breaths

Asthma infection risk ‘goes beyond the airways’

Study explores impact of altitude and anemia in children with pneumonia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News